|
|
 |
|
Viewing report
|
|
|
|
Urinary Incontinence and Overactive Bladder - The Perspective of the Continence Nurse in the US
Datamonitor, April 2006, Pages: 54
Urinary incontinence and overactive bladder disorders are estimated to affect more than 10% of the female population. However, presentation, diagnosis and treatments rates are poor. In the US, the employment of Continence Nurses provides an ideal opportunity to ensure that patients are able to gain access to expert advice and treatment.
Scope of this title:
- Assessment of the responsibilities of the US Continence Nurse including their role in the referral pathway, diagnosis and prescribing of drug therapy
- Evaluation of reasons influencing patient presentation including educational and marketing campaigns
- Analysis of treatment methods employed, influences on treatment choice and perception of current drug therapies
- Identification of unmet needs and potential drivers of change
Highlights of this title:
Continence Nurses in the US play a varied role in the management of urinary incontinence and overactive bladder patients, with over two thirds recommending or prescribing pharmacological therapies. Pharmaceutical companies promoting pharmacological therapies in the US should consider Continence Nurses as key targets.
For more than 50% of patients presenting to Continence Nurses, this is the first healthcare professional that the patient will have spoken to about their condition; frequently identified as a direct result of presenting for another condition. Therefore, Continence Nurses are vital to the diagnosis and referral of this subgroup of patients.
Continence Nurses are likely to have more time than other physicians to discuss the nature of symptoms and side effects with patients. By supporting Continence Nurses, pharmaceutical companies could improve patients knowledge of the condition and its treatment, thereby improving treatment retention and switching rates.
Reasons to order your copy:
- Understand the role of Continence Nurses in the treatment of urinary incontinence and overactive bladder for strategic product planning and targeting
- Evaluate methods for improving presentation rates and thereby utilization of treatments for urinary incontinence and overactive bladder disorders
- Identify concerns of Continence Nurses and patients regarding current treatment and unmet needs
Customers who bought this item also bought
Management of Urinary Incontinence and Overactive Bladder - A Global Overview
Dry Overactive Bladder - A Precursor to Wet Overactive Bladder?
Prescribing for Elderly Patients
Mixed Urinary Incontinence - An Opportunity for Novel Drug Therapies
Strategic Perspectives 2002: CNS Disorders in Women - Urinary Incontinence
Urge Urinary Incontinence - Poor Differentiation Limiting New Product Uptake
European Urinary Incontinence Therapeutics Markets
Urinary Incontinence Devices Market: An Analysis
Urinary Incontinence: Market Update - Growing Market Brings Opportunities for New Drugs
Urinary Incontinence: Major Milestones
Trends and Developments in the European Urinary Incontinence
A Nurses Guide to Caring for Cardiac Intervention Patients
|
|
|
|
